THE 2-MINUTE RULE FOR ABBV-744 AND OTHER BRD4 INHIBITORS COMPARISON

In Segment A, participants will acquire distinctive doses and schedules of oral ABBV-744 pill to recognize Protected dosing regimen. Additional contributors might be enrolled for the recognized monotherapy dosign routine. In Segment B, members will obtain oral ruxolitinib and ABBV-744 will probably be given as "increase-on" therapy. In Section C, p